Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Antonia, S. J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Kurata, T.; Chiappori, A.; Lee, K. H.; de Wit, M.; Cho, B. C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y. -C.; Karapetis, C. S.; Hiret, S.; Ostoros, G.; Kubota, K.; Gray, J. E.; Paz-Ares, L.; Carpeno, J. de Castro; Faivre-Finn, C.; Reck, M.; Vansteenkiste, J.; Spigel, D. R.; Wadsworth, C.; Melillo, G.; Taboada, M.; Dennis, P. A.; Ozguroglu, M.; PACIFIC Investigators

Publication Date

  • December 13, 2018

webpage

published in

category

start page

  • 2342

end page

  • 2350

volume

  • 379

issue

  • 24